Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,796.00
(
0.00%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
109.75
(
2.97%
)
Bitcoin
70,173.45
(
-1.50%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 77
Posts 4790
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Re: DewDiligence post# 165073

Wednesday, 08/07/2013 10:48:14 PM

Wednesday, August 07, 2013 10:48:14 PM

Post# of 257257
XOMA -

Behçet’s is not a strong enough indication to be the centerpiece of the company’s business model.



1) You completely missed my point. --- "Initial indication" "Priming"

2) On a completely separate topic... I would suggest it is odd to say that an orphan indication cannot be a centerpiece.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now